Journal List > J Korean Soc Radiol > v.76(5) > 1087794

Park, Shin, Won, Kim, and Lee: Ultrasound-Guided Percutaneous Core Needle Biopsy of Splenic Lesions

Abstract

Purpose

To evaluate the safety and efficacy of ultrasound-guided percutaneous core needle biopsy of splenic lesions.

Materials and Methods

This retrospective study included 30 patients who underwent percutaneous core needle biopsy of their splenic lesions using 18- or 20-gauge needles between January 2001 and July 2016 in a single tertiary care center. The characteristics of the splenic lesions were determined by reviewing the ultrasound and computed tomography examinations. Acquisition rate and diagnostic accuracy were calculated, using pathologic results of the splenectomy specimen, clinical course and/or imaging follow-up as a reference standard. Post-procedure complications were identified from electronic medical records, laboratory findings and computed tomography images. Seventy-three specimens were obtained from the 30 patients and splenectomy was performed in 2 patients.

Results

Twenty-nine of the 30 patients had focal splenic lesions, while the remaining patient had homogeneous splenomegaly. Acquisition rate and diagnostic accuracy were 80.0% (24/30) and 76.7% (23/30), respectively. Perisplenic hemorrhage without hemodynamic instability developed in one patient.

Conclusion

Ultrasound-guided percutaneous core needle biopsy of splenic lesions is a safe method for achieving a histopathologic diagnosis and can be considered as an alternative to splenectomy in patients with a high risk of splenectomy-related complications.

Figures and Tables

Fig. 1

A 66-year-old male with perisplenic hemorrhage after core needle biopsy.

A. Axial computed tomography (CT) obtained for evaluation of fever shows mild splenomegaly (maximal diameter, 13 cm).
B. Axial fused positron emission tomography-CT image shows mildly increased 18F-fluorodeoxyglucose uptake in the spleen (maximum standardized uptake value, 3.0). The differential diagnoses included infection and hematologic malignancy.
C. Percutaneous ultrasound-guided core needle biopsy of the spleen was performed using an 18-G needle. The arrowheads indicate the tip of the biopsy needle. Histopathologic examination showed inflammatory infiltrates without evidence of malignancy.
D. Follow-up CT scan obtained 1 day after the procedure to evaluate a decrease in blood hemoglobin levels (8.0 g/dL to 6.3 g/dL) shows perisplenic hemorrhage (arrowheads) and probable active extravasation of contrast media (arrow). The patient showed no hemodynamic instability and improved with supportive management.
jksr-76-303-g001
Fig. 2

A 66-year-old female patient with known lung cancer: case with a nondiagnostic histopathologic result.

A. Axial CT shows multiple low density lesions in the spleen, which were considered as possible splenic metastases.
B. US examination shows a 1.4-cm hypoechoic lesion in the spleen. The index mass and other lesions were poorly visualized owing to poor sonic window. Needle approach was hindered by narrow intercostal space of the patient. The histopathologic result was nondiagnostic, and splenectomy revealed sclerosing angiomatoid nodular transformation.
CT = computed tomography, US = ultrasound
jksr-76-303-g002
Fig. 3

A 43-year-old male patient with splenic hemangiomas: case with a favorable result.

A. Axial CT shows numerous hypointense lesions in the spleen.
B. US examination shows multiple hyperechoic lesions in the spleen, one of which was biopsied using an 18-G core needle. The histopathologic diagnosis was hemangioma.
CT = computed tomography, US = ultrasound
jksr-76-303-g003
Table 1

Clinical and Radiological Characteristics of 30 Patients and Their Splenic Lesions

jksr-76-303-i001
Number of Patients
Symptoms at presentation
 Fever 7
 Left flank pain 5
 Generalized weakness 3
 Hematemesis 1
 Asymptomatic 14
Clinical impression
 Lymphoma 11
 Primary benign mass 8
 Infection 5
 Metastasis 4
 Sarcoidosis 1
 Sarcoma 1
Characteristics of splenic lesions
 Number of splenic lesions Number of patients*
  Solitary 10
  2–5 6
  6 or more 13
 Margin Number of patients*
  Ill-defined 9
  Well-defined 20
 Internal attenuation (homogeneity) Number of patients*
  Homogeneous 22
  Heterogeneous 7
Internal attenuation (CT number) 81.4 ± 23.5 HU*
Maximal diameter of largest splenic lesions 3.6 ± 2.2 cm*
Maximal diameter of spleen 11.6 ± 2.4 cm

*n = 29 (excluding one patient with splenomegaly without focal lesions).

CT = computed tomography, HU = Hounsfield unit

Table 2

Histopathologic Results of Ultrasound-Guided Core Needle Biopsy of Splenic Lesions in 30 Patients

jksr-76-303-i002
Result Number of Patients
Malignant
 Non-Hodgkin’s lymphoma (B cell) 8
 Non-Hodgkin’s lymphoma (T cell) 2
 Angiosarcoma 1
 Pleomorphic rhabdomyosarcoma 1
Benign
 Hemangioma 3
 Lymphangioma 2
 Tuberculosis 2
 Sclerosing angiomatoid nodular transformation 2
 Total necrosis and fibrosis 1
 Sarcoidosis 1
 Inflammatory infiltration 1
Nondiagnostic* 6
Total 30

*Nondiagnostic results include normal splenic parenchyma (n = 2), splenic congestion (n = 2), reactive mesothelial cells (n = 1) and normal renal parenchyma (n = 1).

Table 3

Radiologic Impression, Histopathologic Results, Modalities of Further Evaluation and Final Diagnosis in 6 Patients with Nondiagnostic Results on Ultrasound-Guided Percutaneous Core Needle Biopsy

jksr-76-303-i003
Patient Number Impression Histopathology Further Evaluation Final Diagnosis
1 Lymphoma Splenic congestion Bone marrow biopsy Tuberculosis
2 Metastasis Reactive mesothelial cells None (follow-up) NA
3 Pancreatic tail cancer with splenic invasion Normal splenic parenchyma EUS-guided FNA Poorly differentiated carcinoma
4 Metastasis Normal renal parenchyma Splenectomy SANT
5 Hamartoma Splenic congestion None (follow-up) NA
6 Tuberculosis Normal splenic parenchyma None (follow-up) NA

EUS = endoscopic ultrasound, FNA = fine needle aspiration, NA = not available, SANT = sclerosing angiomatoid nodular transformation

References

1. Compérat E, Bardier-Dupas A, Camparo P, Capron F, Charlotte F. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med. 2007; 131:965–969.
2. Cadili A, de Gara C. Complications of splenectomy. Am J Med. 2008; 121:371–375.
3. Lehne G, Hannisdal E, Langholm R, Nome O. A 10-year experience with splenectomy in patients with malignant non-Hodgkin's lymphoma at the Norwegian Radium Hospital. Cancer. 1994; 74:933–939.
4. Machado NO, Grant CS, Alkindi S, Daar S, Al-Kindy N, Al Lamki Z, et al. Splenectomy for haematological disorders: a single center study in 150 patients from Oman. Int J Surg. 2009; 7:476–481.
5. Keogan MT, Freed KS, Paulson EK, Nelson RC, Dodd LG. Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness. AJR Am J Roentgenol. 1999; 172:933–937.
6. Quinn SF, vanSonnenberg E, Casola G, Wittich GR, Neff CC. Interventional radiology in the spleen. Radiology. 1986; 161:289–291.
7. Solbiati L, Bossi MC, Bellotti E, Ravetto C, Montali G. Focal lesions in the spleen: sonographic patterns and guided biopsy. AJR Am J Roentgenol. 1983; 140:59–65.
8. Gómez-Rubio M, López-Cano A, Rendón P, Muñoz-Benvenuty A, Macías M, Garre C, et al. Safety and diagnostic accuracy of percutaneous ultrasound-guided biopsy of the spleen: a multicenter study. J Clin Ultrasound. 2009; 37:445–450.
9. Lieberman S, Libson E, Maly B, Lebensart P, Ben-Yehuda D, Bloom AI. Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma. AJR Am J Roentgenol. 2003; 181:1025–1027.
10. Muraca S, Chait PG, Connolly BL, Baskin KM, Temple MJ. US-guided core biopsy of the spleen in children. Radiology. 2001; 218:200–206.
11. Venkataramu NK, Gupta S, Sood BP, Gulati M, Rajawanshi A, Gupta SK, et al. Ultrasound guided fine needle aspiration biopsy of splenic lesions. Br J Radiol. 1999; 72:953–956.
12. Olson MC, Atwell TD, Harmsen WS, Konrad A, King RL, Lin Y, et al. Safety and accuracy of percutaneous image-guided core biopsy of the spleen. AJR Am J Roentgenol. 2016; 206:655–659.
13. McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology. 2011; 260:699–708.
14. Liang P, Gao Y, Wang Y, Yu X, Yu D, Dong B. US-guided percutaneous needle biopsy of the spleen using 18-gauge versus 21-gauge needles. J Clin Ultrasound. 2007; 35:477–482.
15. Patel N, Dawe G, Tung K. Ultrasound-guided percutaneous splenic biopsy using an 18-G core biopsy needle: our experience with 52 cases. Br J Radiol. 2015; 88:20150400.
16. Civardi G, Vallisa D, Bertè R, Giorgio A, Filice C, Caremani M, et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol. 2001; 67:93–99.
17. Kim SH, Min YI, Lee IC, Lee MG, Auh YH, Hyun CD. Fine-needle aspiration of splenic lesions. J Korean Radiol Soc. 1994; 31:921–924.
18. Lindgren PG, Hagberg H, Eriksson B, Glimelius B, Magnusson A, Sundström C. Excision biopsy of the spleen by ultrasonic guidance. Br J Radiol. 1985; 58:853–857.
TOOLS
Similar articles